# Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

> **NCT01511237** · PHASE3 · COMPLETED · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 379 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine, zidovudine, lamivudine

## Key facts

- **NCT ID:** NCT01511237
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-06
- **Final completion:** 2017-03
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2021-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511237, "Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01511237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*